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Abstract
Background: Cytokines and hormones, including insulin, are known to modulate the hypothalamic-pituitary-testes
axis and steroidogenesis, both centrally and peripherally. In the context of chronic inflammation and
hyperinsulinaemia mediating male hypogonadism associated with obesity, metabolic syndrome and type 2
diabetes mellitus, these mechanisms are poorly understood and the impact of cytokines and insulin on Leydig cell
steroidogenesis has not been fully elicited. This study aimed to further investigate the in vitro impact of TNFα, IL1ß,
IL6, IL8 and insulin on Leydig cell function and steroidogenesis.
Methods: hCG-stimulated TM3 Leydig cells were exposed to various concentrations of TNFα, IL1ß, IL6, IL8 (100 ng/
ml, 10 ng/ml, 1 ng/ml and 0.1 ng/ml) and insulin (10 ng/ml, 1 ng/ml, 0.1 ng/ml and 0.01 ng/ml) in optimal cell
culture conditions over 48 h. Cell viability (XTT) and testosterone and progesterone concentrations (ELISA) were
assessed using standardised laboratory techniques.
Results: TNFα significantly decreased cell viability and progesterone and testosterone concentrations in a dose-
dependent relationship. IL1ß and IL6 had a subtle but significant negative effect on cell viability and testosterone
concentrations, with a marked significant decrease in progesterone concentration at all concentrations investigated.
IL8 showed an increase in cell viability, with no significant effect on testosterone concentrations alongside a
significant decrease in progesterone concentrations. Insulin significantly increased cell viability and testosterone
concentrations in a dose dependent relationship, but interestingly significantly decreased progesterone
concentrations.
Conclusions: The inflammatory cytokines TNFα, IL1β and IL6 cause a dose dependent decline in steroidogenesis in
TM3 Leydig cells. These results suggest that chronic inflammation may downregulate steroidogenesis in males via
direct modulation of Leydig cell function. However, IL8 may stimulate TM3 Leydig cell growth. Insulin is associated
with a dose-dependent increase in testosterone synthesis, with a significant decline in progesterone synthesis. With
the phenomenon of insulin resistance, the literature is unclear on the potential role of hyperinsulinaemia in
steroidogenesis. Further studies are warranted in order to fully elicit the molecular mechanisms and interactions of
these molecules on male steroidogenesis.
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Background
Evidence suggests that immune regulating cytokines, in-
cluding TNFα [1], IL1 [2] and IL6 [3], and hormones
such as insulin [4], modulate the hypothalamic-pituitary-
testes (HPT) axis. These effects are mediated centrally
via modulating GnRH and LH, and peripherally via dir-
ect action on Leydig cells and Sertoli cells [1, 3, 5]. Opti-
mal Leydig cell function within the HPT context is
critical for steroidogenesis cascades and primarily testos-
terone production, a central hormone for male fertility
and general male health and well-being [5, 6].
Testosterone is a steroid hormone primarily produced
by Leydig cells in the interstitial space of the testes [7].
The role of testosterone in male fertility is well defined,
particularly via action on Sertoli cells to promote sperm-
atogenesis [8]. Additional roles for testosterone include
muscle formation, body mass composition and fat regu-
lation, bone mineralisation and cognitive functions [7].
Male hypogonadism, characterised by testosterone de-
ficiency and relevant clinical features, affects approxi-
mately 6% of males with an increasing incidence and
prevalence globally in recent years [5]. Although an un-
common underlying cause of male infertility, serum total
and free testosterone concentration should be consid-
ered in the assessment of male infertility cases [7]. Clin-
ical features of hypogonadism include sexual
dysfunction, reduced muscle strength, increased abdom-
inal adiposity, sleep disturbance and psychological dis-
turbances, and co-morbidities such as dyslipidaemia,
hypertension and hyperglycaemia [5]. There are numer-
ous potential causes of male hypogonadism, which can
be further classified as testicular failure (primary) or of
hypothalamic or pituitary origin (secondary; hypogona-
dotropic) hypogonadism [7]. Although serious acute and
chronic inflammatory pathology is associated with pri-
mary gonadal failure [5, 9], obesity and related co-
morbidities (e.g. metabolic syndrome and type 2 diabetes
mellitus) are considered to be the single most common
cause of male hypogonadism, affecting more than 50%
of obese males [10, 11].
Traditionally, the steroid hormone progesterone has
been viewed as an unimportant precursor hormone in
male physiology. However, progesterone is an important
modulator of male endocrine and reproductive function
[12, 13]. Progesterone in men is synthesised primarily in
the adrenal glands, with some production in the testes,
and is an essential precursor for all steroid hormones, in-
cluding testosterone. Progesterone further regulates the
hypothalamus and pituitary gland in the synthesis of
GnRH and gonadotropins (LH & FSH), respectively, and
regulates sexual behaviour in the brain. Evidence also sug-
gests that progesterone has various modulating functions
in the central nervous system in males, and therefore af-
fects mood, behaviour and cognitive functions [12].
Although numerous cytokines and insulin are known
to modulate the HPT axis, the role of these polypeptides
on modulation of male reproduction and steroidogenesis
has not been fully elicited and requires further investiga-
tion [1, 3]. Inflammatory cytokines are increasingly asso-
ciated with male hypogonadism, and a direct causal
association is postulated [5]. Furthermore, this is rele-
vant in light of the interaction between chronic inflam-
mation, hyperinsulinaemia and male hypogonadism that
may mediate obesity, metabolic syndrome and type 2
diabetes mellitus related male reproductive dysfunction
and hypogonadism [14–16]. Sex steroids and inflamma-
tory biomarkers are known to be associated with the
pathogenesis of various chronic and degenerative dis-
eases in men, although these relationships remain poorly
understood [17].
Within this context, the impact and associated mecha-
nisms of action of inflammatory cytokines and insulin
on steroidogenesis is required. As testosterone synthesis
is predominantly in Leydig cells of males [18], the aim of
this study was to investigate the impact of inflammatory
cytokines (TNFα, IL1β, IL6 and IL8) and insulin on ste-
roidogenesis using a TM3 mouse Leydig cell line. Results
of this study will be of interest to further understand
how steroidogenesis may be modulated in chronic in-
flammatory diseases and obesity related metabolic
complications.
Methods
A TM3 Leydig cell culture model was used in order to
investigate the effect of insulin and cytokines on cell via-
bility and steroid hormone (testosterone and progester-
one) production. TM3 cells are Leydig cell lines derived
from 11 – 13d mouse testes (ATCC No CRL – 1714,
Manassas, VA, USA). This was an in vitro experimental
study comparing various concentrations of experimental
exposure to a control group.
In brief, for each set of experiments, cells were seeded
and incubated under standard laboratory conditions for
48 h. Following this, the cells were then exposed to vari-
ous concentrations of TNFα, IL1β, IL6, IL8 (0.1, 1, 10,
100 ng/ml) and insulin (0.01, 0.1, 1, 10 ng/ml) in hCG-
enriched (25 mIU/ml) media for a further 48 h. These
experiments were done alongside a control group with
hCG-enriched (25 mIU/ml) media only. For each set of
experiments, all groups were done in duplicate on the
same cell line (n = 2). XTT assays were further done in
duplicate on the culture plates in order to obtain an
average reading for data analysis. Testosterone and pro-
gesterone concentrations were quantified via ELISA in
duplicate, and the mean of these results were entered for
data analysis. Each set of experiments (n = 2) was re-
peated 6 times, providing n = 12 samples for analysis for
each variable investigated. Experimental groups were
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compared to the control groups for cell viability (%), and
testosterone and progesterone concentrations (ng/ml).
Chemicals
Cells were cultured using standard sterile cell culture
techniques, maintained using Dulbecco’s Modified Eagle
Medium F-12 (DMEM/F-12) (Gibco, Johannesburg,
South Africa) with 5% Horse Serum (Gibco), 2.5% Fetal
Bovine Serum (Gibco) and 1% Penicillin-Streptomycin
(Sigma-Aldrich, St. Louis, MO, USA). Cells were cul-
tured in 75 ml culture flasks and incubated at 37 °C with
5% CO2. When confluent, and ready for experimental
preparations, cultured cells were detached using 0.25%
Trypsin/EDTA (Gibco).
Recombinant TNFα, IL1β, IL6 and IL8 appropriate for
mouse cell culture experiments was obtained from
Sigma-Aldrich as a lyophilised powder. As per manufac-
turer’s instructions, powders were reconstituted to
achieve a 100 μg/ml solution. This solution was further
diluted at 1:10 with culture medium in order to achieve
10 μg/ml stock solutions for each cytokine. Aliquots of
this stock solution were frozen at − 20 °C until use. For
each experiment, four concentrations of each cytokine
were used: 100 ng/ml, 10 ng/ml, 1 ng/ml and 0.1 ng/ml.
These were selected based on previous in vitro studies
[19–33] and early experimental exposure of the cyto-
kines to TM3 Leydig cells.
Recombinant insulin appropriate for mouse cell cul-
ture experiments was obtained from Sigma-Aldrich as a
lyophilised powder. As per manufacturer’s instructions,
the powder was reconstituted in 0.01 M hydrochloric
acid (HCl) to achieve a 25 mg/ml solution, which was
further serially diluted with culture medium to achieve a
stock solution of 20 ng/ml. Aliquots of this stock solu-
tion were frozen at − 20 °C until use. For each experi-
ment, four concentrations of insulin were used: 10 ng/
ml, 1 ng/ml, 0.1 ng/ml, 0.01 ng/ml. These concentra-
tions are based on previous literature [34–36] and early
experimental exposure to TM3 Leydig cells in the la-
boratory to determine ideal experimental ranges.
Cell culture
For each experiment, approximately 5000 cells per well
were seeded in 300 μl medium in sterile 96-well plates
and cultured for 48 h. Medium was then removed, and
cells further cultured in experimental medium at the ex-
perimental concentrations for a further 48 h in the pres-
ence of 25 mIU/ml hCG. The respective controls were
exposed to culture medium in the presence of 25 mIU/
ml hCG only. After 48 h of exposure to the experimental
concentrations, the experiments were terminated. Cell
viability and steroid hormone (testosterone and proges-
terone) concentrations were determined for analysis. All
experiments were done in duplicate, and repeated six
times for data analysis variables (n = 12).
Cell viability and proliferation determination
Cell viability was assessed using the Cell Proliferation
Kit II (XTT) (Roche, Illovo, Johannesburg, South Africa).
Under sterile conditions, XTT labelling reagent and the
electron coupling reagent were thawed at 37 °C, mixed
thoroughly, and 1 μl electron coupling reagent was
added to 50 μl XTT labelling reagent as per instructions.
From this, 50 μl XTT labelling mixture was added to
100 μl experimental medium to achieve a final XTT con-
centration of 0.3 mg/ml. This was incubated for 6 h in
the dark at 37 °C. Following incubation, the plate was
read with an ELISA reader (Labtech, East Sussex, UK) at
a wavelength of 450 nm. Cell viability was expressed as a
percentage of XTT binding as compared to the hCG
control group.
Steroid hormone quantifications
Testosterone and progesterone concentrations were de-
termined from experimental cell culture supernatant.
The supernatant was removed as cell culture media from
each experimental well (300 μl) and stored in Eppendorf
vials at − 20 °C until assayed. The testosterone and pro-
gesterone ELISA kits (DRG International, Inc., Spring-
field, New Jersey, USA) were used to determine
testosterone and progesterone concentrations as per
manufacturer instructions. All assays were carried out in
duplicate, with the mean value recorded as the hormone
concentration. Final concentration was quantified based
on the standard curve determined by the supplied stand-
ard concentrations for the assay.
Statistical analysis
Statistical analysis was performed using the MedCalc
software (Version 12.0; Mariakerke, Belgium). All experi-
ments were done in duplicate, and repeated six times
(n = 12). Data was tested for distribution using the
Kolmogorov-Smirnov test. Parametric data (normal dis-
tribution) is expressed as mean ± standard deviation in
standard bar graphs, and experimental groups compared
to the control group using the student T-test. For XTT
analysis, the non-parametric Mann-Whitney test for in-
dependent samples was used to determine statistical sig-
nificance of the experimental outcomes compared to the
control group. The ANOVA one-way analysis of vari-
ance and ANOVA repeated measures analysis of vari-
ance were used to determine trends across increasing
experimental concentrations on testosterone and proges-
terone production. A P-value of < 0.05 was considered
significant.
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Results
Effects of TNFα, IL1β and IL6
Exposure of TM3 Leydig cells to various concentrations of
the inflammatory cytokines TNFα (Fig. 1), IL1β (Fig. 2)
and IL6 (Fig. 3) resulted in significantly decreased cell via-
bility, testosterone and progesterone concentrations com-
pared to the control experiments. For TNFα and IL6,
ANOVA repeated measures analysis and one-way
ANOVA were significant (P < 0.001) for testosterone and
progesterone concentrations, indicating a dose-dependent
decline. For IL1β, there was no significant dose-dependent
decrease in testosterone concentration observed. How-
ever, ANOVA repeated measures analysis and one-way
ANOVA were significant (P < 0.001) for a dose-dependent
decline in progesterone concentrations for IL1β.
Effects of IL8
Exposure of TM3 Leydig cells to the cytokine IL8 re-
sulted in a significant increase in cell viability compared
to control for all concentrations (Fig. 4a). There was no
effect of IL8 exposure observed on testosterone concen-
tration, nor was there a significant dose-dependent
relationship observed for testosterone concentration
(Fig. 4b). However, an immediate and significant de-
crease in progesterone concentration was evident at all
concentrations of IL8 investigated (Fig. 4c). Calculated
over all IL8 concentrations applied, ANOVA repeated
measures analysis (P = 0.002) and one-way ANOVA
(P < 0.001) were significant for progesterone concentra-
tion (Fig. 4c).
Effects of insulin
Exposure of TM3 Leydig cells to insulin resulted in a
significant increase in cell viability at 0.01 ng/ml (P =
0.002), 0.1 ng/ml (P = 0.029) and 10 ng/ml (P = 0.0359)
(Fig. 5a). There was a significant increase in testosterone
concentrations at all experimental concentrations tested,
and increasing concentrations of insulin resulted in a
Fig. 1 Cell viability (a), testosterone (b) and progesterone concentration (c) results for TM3 cell exposure to various concentrations of tumour necrosis
factor-alpha (TNFα). All tested parameters significantly decreased for all concentrations of TNFα. For testosterone and progesterone results, ANOVA
repeated measures analysis of variance was significant (P < 0.001), as was the one-way analysis of variance (P < 0.001)
Leisegang and Henkel Reproductive Biology and Endocrinology  (2018) 16:26 Page 4 of 11
dose-dependent and significant increase in testosterone
production (ANOVA repeated measures analysis: P =
0.015; one-way ANOVA: P < 0.001) (Fig. 5b). However,
the opposite was discovered for the progesterone produc-
tion in which a significant decrease was observed at all ex-
perimental concentrations. Furthermore, there was a
significant and dose-dependent decrease in progesterone
concertation (ANOVA repeated measures analysis: P <
0.001; one-way ANOVA: P < 0.001) (Fig. 5c).
Discussion
Lipophilic steroid hormones are produced via the enzym-
atic cascade termed steroidogenesis. This process can
occur in various tissues (e.g. gonads, adrenal medula and
adipose tissue) [13, 16], and testosterone synthesis in
males is most prominent in the Leydig cells [16, 18]. Pro-
gesterone, although poorly studied, is an important pre-
cursor to testosterone and further has regulatory roles on
male physiology and pathology [12]. This is mostly investi-
gated on male contraception, the treatment of male
hypersexuality and the role of progesterone in fertilisation
[12]. In order to further elicit a possible causal relationship
between inflammation and hyperinsulinaemia on modu-
lating steroidogenesis, this study suggests that inflamma-
tory cytokines negatively influence steroidogenesis
cascades in TM3 Leydig cells, whereas insulin positively
modulates testosterone production.
Tumour necrosis factor-alpha
TNFα has been suggested to negatively affect the HPT axis,
where in vivo administration is associated with a decrease
in serum testosterone [1, 19]. The results of this study agree
with previous publications that have assessed the impact of
TNFα on Leydig cell function in vitro and in vivo [19–25].
TNFα reduces testosterone production in ranges of 0.1–
100 ng/ml, typically in a dose dependant manner, in Leydig
cells [20–24]. It is plausible that the enzymes mediating
cholesterol uptake into the mitochondria (StAR), conver-
sion to pregnenolone (P450scc), pregnenolone conversion to
progesterone (3βHSD) and progesterone conversion to 17-
Fig. 2 Cell viability (a), testosterone (b) and progesterone (c) results for TM3 cell exposure to various concentrations of interleukin 1-beta (IL1β).
All parameters tested significantly decreased for all concentrations of IL1β. For testosterone, ANOVA repeated measures analysis of variance was
not significant (P = 0.159), nor was the ANOVA one-way analysis of variance (P = 0.256). For progesterone, ANOVA repeated measures analysis of
variance was significant (P < 0.001), as was the one-way analysis of variance (P < 0.001)
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OH-P (CYP17) are all negatively impacted by increasing
TNFα concentrations [20–24]. Furthermore, the significant
decrease in cell viability observed in this study would sug-
gest cellular injury at increasing concentrations of TNFα
exposure, leading to down-regulation of steroidogenesis en-
zyme production as a response to cellular injury [23]. TNFα
was shown in this study to also decrease progesterone syn-
thesis, agreeing agrees previous studies [20, 25] in Leydig
cells. Based on the suggested mechanisms of steroidogen-
esis down-regulation [20–24], this would be an expected
result that has been confirmed in this study.
Interleukin 1-beta
Previous studies on the effect of IL1 on Leydig cell steroid
regulation have provided conflicting results. This appears
to be due to a variety of different stages of puberty in which
primary Leydig cells were obtained from animals [26]. Simi-
lar to this study, IL1β has been shown to decrease hCG-
stimulated testosterone synthesis in a dose dependant man-
ner using concentrations of 1–100 ng/ml [27, 28]. This may
be via a decrease in hCG stimulated cAMP production [27]
and reduced P450scc mRNA transcription [28]. In contrast,
other studies have shown that IL1β did not significantly
alter Leydig cell testosterone synthesis [29], or even in-
creased testosterone synthesis [30].
Similar to this study, IL1 exposure has also previously
been associated with a decrease in progesterone levels
[25]. However, in contrast to this study, Wu and col-
leagues reported that a significant decrease in cell viabil-
ity in TM3 Leydig cells exposed to 0.02 pg/ml IL1β
which was interestingly prevented by co-stimulation of
Sirt1, associated with cellular protection from inflamma-
tory stress [23].
Interleukin 6
The effect of IL6 on Leydig cell function and steroido-
genesis has been less well studied in controlled experi-
ments compared to TNFα and IL1β [3]. However, the
available reports generally agree with the results of this
study. Human application of subcutaneous single doses
Fig. 3 Cell viability (a), testosterone (b) and progesterone (c) results for TM3 cell exposure to various concentrations of interleukin 6 (IL6). All
parameters significantly decreased for all concentrations of IL6. For testosterone and progesterone, ANOVA repeated measures analysis of
variance was significant (P < 0.0001), as was the one-way analysis of variance (P < 0.001)
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of IL6 causes significant short term decreases in testos-
terone levels with increases in LH [31], most marked at
3 μg/Kg [31]. It is also suggested that IL6 compromises
cAMP induced expression of CYP17 and, interestingly,
17β-HSD, at concentrations of 100 ng/ml in primary
mouse Leydig cells [3], resulting in reduced testosterone
synthesis [31, 32]. IL6 also decreases CYP17 and 3βHSD
expression [32]. IL6 reportedly reduces Leydig cell via-
bility at 0.02 pg/ml [23] similarly to this study. Interest-
ingly, in adrenal cells from older adult males, IL6 is
suggested to increase aldosterone, cortisol and DHEA
synthesis [33], up-regulating adrenal steroidogenesis
which is predominantly focused on mineralocorticoids
and glucocorticoids synthesis [1].
Interleukin 8
Unlike TNFα, IL1β and IL6, there appear to be no pub-
lished investigations into the possible effects of IL8 on
steroidogenesis in Leydig cells. In this study, testosterone
concentrations are maintained, but progesterone con-
centrations significantly decreased. It therefore appears
that IL8 may influence progesterone via CYP17 or
P450scc or StAR. As testosterone is not different from
controls over 48 h, this would imply that the Δ5-steroid
pathway is at least maintained, for which CYP17 or
P450scc and StAR are required.
Insulin
The results from this study agrees with reports in which
insulin increases testosterone synthesis in the absence of
insulin resistance [4, 34–38]. Exposure of primary mouse
Leydig cells to 1 μg/ml insulin showed that for one hour
prior to addition of LH for a further 3 h increased tes-
tosterone production compared to no insulin pre-
treatment [34]. Lin et al. [36] also demonstrated insulin
stimulation of testosterone synthesis in a primary rat
Fig. 4 Cell viability (a), testosterone (b) and progesterone (c) results for TM3 cell exposure to various concentrations of interleukin 8 (IL8). Cell
viability was significantly increased for all concentrations, while testosterone concentrations did not significantly change. Contrary, progesterone
concentrations declined significantly. For testosterone, ANOVA repeated measures analysis of variance was not significant (P = 0.052), nor was the
ANOVA one-way analysis of variance (P = 0.187). For progesterone, ANOVA repeated measures analysis of variance was significant (P = 0.002), as
was the one-way analysis of variance (P < 0.001)
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Leydig cell culture model. Furthermore, 24-h exposure
of primary catfish Leydig cells to 1 ng/ml insulin stimu-
lated testosterone synthesis [39]. However, Ahn and col-
leagues [40] demonstrated that insulin binds directly to
insulin receptors on the Leydig cell membrane, leading
to an upregulation of DAX-1 genes expression via the
AKT pathway in MA-10 Leydig cells. This in turn re-
sulted in a downregulation of steroidogenesis in these
cells [40], which is somewhat contrary to the testoster-
one results in this study and others [4, 34–38].
Insulin mediates metabolic and mitogenic effects
through binding to cell surface insulin receptors, leading
to activation of two pathways: the phosphoinositide 3-
kinase (PI3K) and the mitogen-activated protein kinase
(MAPK) pathways. PI3K results in activation of 3-
phosphoinositide-dependent protein kinase 1 (PDK1)
and Akt kinase, mediating most of the cellular effects of
insulin [41]. The activation of the MAPK pathway
generally mediates transcription of factors involved with
cell growth. Effects of metabolites in this pathway result
in vasoconstriction, increased expression of vascular cell
adhesion molecules and growth and mitogenesis of vas-
cular smooth muscle cells [41].
In animals and humans, hyperinsulinaemia and insulin
resistance is closely associated with male hypogonadism
[37, 42], which also conflicts with these in vivo results. In
various cell lines (e.g. hepatocytes, adipocytes, skeletal
muscle), the PI3K/Akt intracellular pathway through
which insulin exerts its effects breakdown with increasing
insulin resistance (hyperinsulinaemia) [41]. The induction
of hyperinsulinaemia in mice results in disruption of ste-
roidogenesis cascades via abnormal activation of the
oestrogen receptor-alpha pathway, contributing to male
hypogonadism pathogenesis [43]. Currently, no significant
data exists in which to further postulate on the direct po-
tential impact of hyperinsulinaemia and insulin resistance
Fig. 5 Cell viability (a), testosterone (b) and progesterone (c) results for TM3 cell exposure to various concentrations of insulin. Cell viability was
significantly increased at 0.01, 0.1 and 1 ng/ml insulin. Testosterone concentrations were significantly increased for all concentrations, while progesterone
concentrations significantly declined. For testosterone, ANOVA repeated measures analysis of variance was significant (P = 0.015), as was the one-way
analysis of variance (P < 0.001). For progesterone, ANOVA repeated measures analysis of variance was statistically significant (P < 0.001), as
was the one-way analysis of variance (P < 0.001)
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on Leydig cell function and steroidogenesis molecular
mechanisms. Further research is required in order to fur-
ther elicit these mechanisms.
There are no significant studies identified that investi-
gate the effect of insulin on progesterone synthesis. In
stark contrast to testosterone concentrations, progester-
one was significantly decreased for all concentrations
assessed, in a dose-dependent manner. As progesterone
is an essential precursor of testosterone, these results
suggest enzymatic activity downstream of progesterone
may be upregulated, and not those upstream. Hypothet-
ically, insulin may stimulate an upregulation of testoster-
one synthesis via the Δ4-steroid pathway, acting on one
or more of these enzymes such as CYP17, CYP17,20 or
17β-HSD. This may also be associated with a down-
regulate 3β-HSD, leading to a decrease in the Δ5-steroid
pathway [44]. Further studies on these mechanisms is
therefore warranted to further elicit the physiological
and pathological mechanisms associated with insulin
and Leydig cell steroidogenesis cascades.
Clinical implications
Adequate Leydig cell function with the central purpose
of testosterone production via steroidogenesis cascades
is critical not only for male reproduction, but in general
male health and well-being [6]. Various cytokines, as
well as insulin, have been suggested to modulate the
HPT axis, and may further regulate steroidogenesis
within Leydig cells directly or indirectly [1, 3, 4]. Obesity
and related metabolic co-morbidities and complications
are closely associated with a low grade, asymptomatic,
systemic and chronic inflammatory state and hyperinsuli-
naemia, amongst other underlying mechanisms [14, 15].
This is also relevant in male ageing and androgen decline
in ageing men, which is associated with increasing inflam-
matory markers and hyperinsulinaemia [45]. Furthermore,
increased systemic inflammatory cytokines and insulin
have correlated with increased seminal concentrations of
cytokines and insulin [14, 15]. As testosterone is critical in
male health and well-being [5, 6], the (patho)physiological
role of cytokines and insulin is relevant within the context
of inflammation in males.
The TH1-lymphocyte associated inflammatory cyto-
kines, specifically TNFα, IL1β, and IL6, are increasingly
associated with male hypogonadism. Although a direct
causal association is postulated, this is poorly under-
stood [5, 9]. This is observed in acute inflammatory (in-
fectious) disease associated with gonadal failure [5], and
low-grade chronic inflammation associated with obesity
and related co-morbidities and complications such as
metabolic syndrome and type 2 diabetes mellitus [15].
Testosterone is also inversely correlated to the inflam-
matory marker C-Reactive Protein (CRP) in males, and
males in lower quintiles of serum testosterone
concentrations are more likely to have increased inflam-
matory markers associated with TNFα and IL6 [17]. In
addition to having immune (down)regulating functions
[17], testosterone therapy reduces inflammatory cytokine
production and improves insulin sensitivity in obese and
metabolic syndrome males [46].
Although poorly researched in males, reduced serum
progesterone is associated with obesity and metabolic
syndrome [44, 47, 48]. This study suggests that an asso-
ciated pro-inflammatory state is associated with reduced
progesterone as observed in observational clinical re-
sults. However, further research, particularly to under-
stand the mechanisms associated with these results, is
required in order to identify potentially novel thera-
peutic targets in males with chronic inflammation.
Insulin independently stimulates testosterone produc-
tion and simultaneously inhibits SHBG in normal weight
and obese males [4]. Furthermore, insulin resistance is
closely associated with low testosterone in males [14, 42].
There is a close relationship between insulin sensitivity
and testosterone concentrations in men across a wide
range of glucose intolerance, including those with T2DM,
and independent of SHBG concentrations [49]. This study
is consistent with in vivo evidence from animals and
humans that insulin increased testosterone production in
insulin sensitive males [49]. However, insulin sensitivity is
directly related to testosterone synthesis [34, 36]. Insulin
appears to activate the Akt kinase pathway within Leydig
cells, which likely mediates the role of this hormone in
steroidogenesis [40]. It is further known that this
intracellular pathway breaks down with insulin resist-
ance in other cell lines [41]. Numerous studies have
shown that TNFα can impair insulin signalling in he-
patocytes, adipose tissue and skeletal muscle [50]. It
is therefore feasible that induction of insulin resist-
ance may result in the inability of insulin to promote
testosterone synthesis in Leydig cells, and further
contribute to hypogonadism. Further studies to
understand the mechanism of insulin, including the
potential induction of insulin resistance, on Leydig
cell function and steroidogenesis required.
Strengths and limitations of the study
This in vitro study was done under standard and con-
trolled laboratory conditions. Experiments on each ex-
posure were done in duplicate and assays further done
on duplicate to ensure reliability of the results obtained.
Experiments were replicated six times, and statistical
analysis on the data is appropriate. This study is limited
specifically in the number of variables investigated, due
to the exploratory nature and aims of the study. Caution
should be made in the interpretation of the results
within the context of the existing literature, as different
in vitro and in vivo models and methods are used in the
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studies reported. Implications of the results within the
broader clinical context, although relevant, require fur-
ther investigation, and these results are not able to dir-
ectly prove causation relevant to clinical practice.
Conclusions
The inflammatory cytokines TNFα, IL1β and IL6 cause a
dose dependent decline in steroidogenesis in TM3 Ley-
dig cells over 48 h. These results suggest that chronic in-
flammation may downregulate steroidogenesis in males
via direct modulation of Leydig cell function. However,
IL8 appears to minimally affect testosterone production
in the concentrations observed, with an increase in cell
viability and decrease in progesterone concentrations
which may suggest inhibition of progesterone synthesis
from cholesterol via 17-OH pregnenolone. Insulin was
observed to have a dose-dependent increase in testoster-
one synthesis alongside a significant decline in proges-
terone synthesis, indicating insulin may directly act on
Leydig cells as part of steroid hormone regulation. With
the phenomenon of insulin resistance, the literature is
unclear on the potential role of hyperinsulinaemia in ste-
roidogenesis. Further studies are warranted in order to
fully elicit the molecular mechanisms and interactions of
these molecules on male steroidogenesis.
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